Quaker Chemical Financials
This page shows Quaker Chemical (KWR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Stable gross profit gave way to an overhead and investment squeeze, leaving cash positive but sharply weaker earnings in FY2025.
Revenue stayed near$1.9B and gross margin held at36.0% , so FY2025’s earnings collapse did not start with a demand break or raw-margin shock. Instead, SG&A and R&D absorbed more of each gross-profit dollar, pushing operating margin to2.8% from10.6% ; the company still produced free cash flow despite a small net loss, so reported earnings deteriorated faster than cash generation.
Balance-sheet repair reversed in FY2025: long-term debt rose to
Working capital got heavier: inventory increased to
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Quaker Chemical's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Quaker Chemical has an operating margin of 2.8%, meaning the company retains $3 of operating profit per $100 of revenue. This results in a moderate score of 37/100, indicating healthy but not exceptional operating efficiency. This is down from 10.6% the prior year.
Quaker Chemical's revenue grew a modest 2.7% year-over-year to $1.9B. This slow but positive growth earns a score of 31/100.
Quaker Chemical carries a low D/E ratio of 0.61, meaning only $0.61 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 90/100, indicating a strong balance sheet with room for future borrowing.
Quaker Chemical's current ratio of 2.42 indicates adequate short-term liquidity, earning a score of 45/100. The company can meet its near-term obligations, though with limited headroom.
Quaker Chemical has a free cash flow margin of 4.3%, earning a moderate score of 43/100. The company generates positive cash flow after capital investments, but with room for improvement.
Quaker Chemical generates a -0.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 20/100. This is down from 8.6% the prior year.
Quaker Chemical scores 2.30, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Quaker Chemical passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Quaker Chemical generates $-54.84 in operating cash flow ($136.5M OCF vs -$2.5M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Quaker Chemical earns $1.2 in operating income for every $1 of interest expense ($53.0M vs $42.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Quaker Chemical generated $1.9B in revenue in fiscal year 2025. This represents an increase of 2.7% from the prior year.
Quaker Chemical's EBITDA was $118.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 53.5% from the prior year.
Quaker Chemical reported -$2.5M in net income in fiscal year 2025. This represents a decrease of 102.1% from the prior year.
Quaker Chemical earned $-0.14 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 102.2% from the prior year.
Cash & Balance Sheet
Quaker Chemical generated $80.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 50.5% from the prior year.
Quaker Chemical held $179.8M in cash against $834.9M in long-term debt as of fiscal year 2025.
Quaker Chemical paid $1.99 per share in dividends in fiscal year 2025. This represents an increase of 5.9% from the prior year.
Quaker Chemical had 17M shares outstanding in fiscal year 2025. This represents a decrease of 1.9% from the prior year.
Margins & Returns
Quaker Chemical's gross margin was 36.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.3 percentage points from the prior year.
Quaker Chemical's operating margin was 2.8% in fiscal year 2025, reflecting core business profitability. This is down 7.8 percentage points from the prior year.
Quaker Chemical's net profit margin was -0.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 6.5 percentage points from the prior year.
Quaker Chemical's ROE was -0.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 8.8 percentage points from the prior year.
Capital Allocation
Quaker Chemical invested $60.7M in research and development in fiscal year 2025. This represents an increase of 5.9% from the prior year.
Quaker Chemical spent $41.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 15.7% from the prior year.
Quaker Chemical invested $55.9M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 33.6% from the prior year.
KWR Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $468.5M-5.1% | $493.8M+2.2% | $483.4M+9.1% | $442.9M-0.3% | $444.1M-3.9% | $462.3M-0.3% | $463.6M-1.3% | $469.8M |
| Cost of Revenue | $303.0M-3.2% | $313.0M+0.4% | $311.7M+10.7% | $281.7M-2.2% | $287.9M-0.6% | $289.7M+0.7% | $287.8M-0.1% | $288.2M |
| Gross Profit | $165.5M-8.5% | $180.9M+5.3% | $171.7M+6.5% | $161.3M+3.2% | $156.2M-9.5% | $172.5M-1.8% | $175.7M-3.2% | $181.6M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $130.3M+3.0% | $126.5M-0.1% | $126.6M+6.3% | $119.0M-5.1% | $125.4M+6.1% | $118.2M+1.1% | $116.9M-5.8% | $124.2M |
| Operating Income | $31.2M-33.0% | $46.6M+188.8% | -$52.5M-290.1% | $27.6M-4.8% | $29.0M-43.9% | $51.7M-11.5% | $58.4M+5.3% | $55.5M |
| Interest Expense | $10.4M-1.5% | $10.6M-14.8% | $12.4M+35.2% | $9.2M-4.6% | $9.6M-10.6% | $10.8M-6.6% | $11.5M+2.2% | $11.3M |
| Income Tax | $2.3M-74.9% | $9.3M+69.3% | $5.5M-27.4% | $7.5M-14.8% | $8.8M-27.3% | $12.2M-22.9% | $15.8M+26.1% | $12.5M |
| Net Income | $20.7M-32.1% | $30.5M+145.8% | -$66.6M-615.2% | $12.9M-8.9% | $14.2M-56.1% | $32.3M-7.3% | $34.9M-1.0% | $35.2M |
| EPS (Diluted) | N/A | $1.75+146.3% | $-3.78-617.8% | $0.73 | N/A | $1.81-6.7% | $1.94-0.5% | $1.95 |
KWR Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.8B-0.7% | $2.8B-1.1% | $2.8B+6.9% | $2.7B+2.1% | $2.6B-4.6% | $2.7B+2.4% | $2.7B-1.6% | $2.7B |
| Current Assets | $921.2M-2.6% | $946.0M-2.9% | $974.1M+6.8% | $912.4M+4.1% | $876.4M-6.9% | $941.9M+2.5% | $919.1M-1.5% | $933.0M |
| Cash & Equivalents | $179.8M+4.5% | $172.0M-14.8% | $201.9M+8.4% | $186.2M-1.4% | $188.9M-10.9% | $212.1M+12.5% | $188.6M-3.7% | $195.8M |
| Inventory | $265.8M | N/A | N/A | N/A | $227.5M | N/A | N/A | N/A |
| Accounts Receivable | $417.2M-4.4% | $436.2M-0.3% | $437.4M+4.5% | $418.7M+4.6% | $400.1M-5.3% | $422.7M-0.3% | $423.9M-3.7% | $440.0M |
| Goodwill | $501.7M0.0% | $501.8M-0.1% | $502.4M-4.2% | $524.7M+1.1% | $518.9M-2.6% | $532.5M+2.9% | $517.6M-1.0% | $522.6M |
| Total Liabilities | $1.4B-2.0% | $1.4B-3.6% | $1.5B+17.6% | $1.3B+1.7% | $1.3B-2.6% | $1.3B+1.0% | $1.3B-3.5% | $1.3B |
| Current Liabilities | $380.2M-0.8% | $383.4M+0.9% | $380.1M+1.9% | $372.8M-1.8% | $379.8M+2.3% | $371.3M+6.1% | $350.1M0.0% | $350.2M |
| Long-Term Debt | $834.9M-0.4% | $838.5M-6.6% | $898.0M+28.5% | $698.8M+4.4% | $669.6M-4.4% | $700.6M-0.4% | $703.7M-5.0% | $740.4M |
| Total Equity | $1.4B+0.7% | $1.4B+1.6% | $1.3B-3.1% | $1.4B+2.4% | $1.4B-6.4% | $1.4B+3.6% | $1.4B+0.3% | $1.4B |
| Retained Earnings | $596.6M+2.0% | $584.7M+3.8% | $563.1M-11.8% | $638.1M+0.7% | $633.7M+0.9% | $628.1M+3.9% | $604.4M+4.6% | $577.7M |
KWR Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $46.5M-9.4% | $51.4M+23.6% | $41.6M+1463.0% | -$3.0M-104.8% | $63.1M-7.2% | $68.0M+46.8% | $46.3M+70.0% | $27.2M |
| Capital Expenditures | $22.2M+66.6% | $13.3M+67.6% | $8.0M-35.4% | $12.3M-45.1% | $22.5M+173.4% | $8.2M+23.2% | $6.7M+49.4% | $4.5M |
| Free Cash Flow | $24.3M-36.1% | $38.0M+13.2% | $33.6M+318.6% | -$15.4M-137.9% | $40.6M-32.1% | $59.8M+50.8% | $39.6M+74.1% | $22.8M |
| Investing Cash Flow | -$21.1M-71.6% | -$12.3M+92.6% | -$167.3M-1147.5% | -$13.4M+34.8% | -$20.6M+9.0% | -$22.6M-476.4% | -$3.9M+86.6% | -$29.3M |
| Financing Cash Flow | -$17.4M+74.5% | -$68.3M-150.0% | $136.6M+1146.8% | $11.0M+119.7% | -$55.7M-100.9% | -$27.7M+39.6% | -$45.9M-798.8% | $6.6M |
| Dividends Paid | $8.8M+4.4% | $8.4M-1.6% | $8.6M0.0% | $8.6M-0.9% | $8.6M+6.1% | $8.2M-0.4% | $8.2M0.0% | $8.2M |
| Share Buybacks | $5.0M+32.1% | $3.8M | N/A | N/A | $26.3M+73.9% | $15.1M | N/A | N/A |
KWR Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.3%-1.3pp | 36.6%+1.1pp | 35.5%-0.9pp | 36.4%+1.2pp | 35.2%-2.2pp | 37.3%-0.6pp | 37.9%-0.7pp | 38.6% |
| Operating Margin | 6.7%-2.8pp | 9.4%+20.3pp | -10.9%-17.1pp | 6.2%-0.3pp | 6.5%-4.7pp | 11.2%-1.4pp | 12.6%+0.8pp | 11.8% |
| Net Margin | 4.4%-1.7pp | 6.2%+19.9pp | -13.8%-16.7pp | 2.9%-0.3pp | 3.2%-3.8pp | 7.0%-0.5pp | 7.5%+0.0pp | 7.5% |
| Return on Equity | 1.5%-0.7pp | 2.2%+7.2pp | -5.0%-5.9pp | 0.9%-0.1pp | 1.1%-1.2pp | 2.2%-0.3pp | 2.5%-0.0pp | 2.5% |
| Return on Assets | 0.7%-0.3pp | 1.1%+3.4pp | -2.3%-2.8pp | 0.5%-0.1pp | 0.5%-0.6pp | 1.2%-0.1pp | 1.3%+0.0pp | 1.3% |
| Current Ratio | 2.42-0.0 | 2.47-0.1 | 2.56+0.1 | 2.45+0.1 | 2.31-0.2 | 2.54-0.1 | 2.63-0.0 | 2.66 |
| Debt-to-Equity | 0.610.0 | 0.61-0.1 | 0.67+0.2 | 0.500.0 | 0.490.0 | 0.48-0.0 | 0.50-0.0 | 0.53 |
| FCF Margin | 5.2%-2.5pp | 7.7%+0.7pp | 7.0%+10.4pp | -3.5%-12.6pp | 9.1%-3.8pp | 12.9%+4.4pp | 8.6%+3.7pp | 4.9% |
Similar Companies
Frequently Asked Questions
What is Quaker Chemical's annual revenue?
Quaker Chemical (KWR) reported $1.9B in total revenue for fiscal year 2025. This represents a 2.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Quaker Chemical's revenue growing?
Quaker Chemical (KWR) revenue grew by 2.7% year-over-year, from $1.8B to $1.9B in fiscal year 2025.
Is Quaker Chemical profitable?
No, Quaker Chemical (KWR) reported a net income of -$2.5M in fiscal year 2025, with a net profit margin of -0.1%.
What is Quaker Chemical's EBITDA?
Quaker Chemical (KWR) had EBITDA of $118.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Quaker Chemical have?
As of fiscal year 2025, Quaker Chemical (KWR) had $179.8M in cash and equivalents against $834.9M in long-term debt.
What is Quaker Chemical's gross margin?
Quaker Chemical (KWR) had a gross margin of 36.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Quaker Chemical's operating margin?
Quaker Chemical (KWR) had an operating margin of 2.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Quaker Chemical's net profit margin?
Quaker Chemical (KWR) had a net profit margin of -0.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Quaker Chemical pay dividends?
Yes, Quaker Chemical (KWR) paid $1.99 per share in dividends during fiscal year 2025.
What is Quaker Chemical's return on equity (ROE)?
Quaker Chemical (KWR) has a return on equity of -0.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Quaker Chemical's free cash flow?
Quaker Chemical (KWR) generated $80.6M in free cash flow during fiscal year 2025. This represents a -50.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Quaker Chemical's operating cash flow?
Quaker Chemical (KWR) generated $136.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Quaker Chemical's total assets?
Quaker Chemical (KWR) had $2.8B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Quaker Chemical's capital expenditures?
Quaker Chemical (KWR) invested $55.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Quaker Chemical spend on research and development?
Quaker Chemical (KWR) invested $60.7M in research and development during fiscal year 2025.
What is Quaker Chemical's current ratio?
Quaker Chemical (KWR) had a current ratio of 2.42 as of fiscal year 2025, which is generally considered healthy.
What is Quaker Chemical's debt-to-equity ratio?
Quaker Chemical (KWR) had a debt-to-equity ratio of 0.61 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Quaker Chemical's return on assets (ROA)?
Quaker Chemical (KWR) had a return on assets of -0.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Quaker Chemical's Altman Z-Score?
Quaker Chemical (KWR) has an Altman Z-Score of 2.30, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Quaker Chemical's Piotroski F-Score?
Quaker Chemical (KWR) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Quaker Chemical's earnings high quality?
Quaker Chemical (KWR) has an earnings quality ratio of -54.84x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Quaker Chemical cover its interest payments?
Quaker Chemical (KWR) has an interest coverage ratio of 1.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Quaker Chemical?
Quaker Chemical (KWR) scores 44 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.